| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/03/2003 | US20030064977 Viricides |
| 04/03/2003 | US20030064972 Using thiazolidinone compound |
| 04/03/2003 | CA2461709A1 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | CA2461603A1 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | CA2461363A1 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | CA2461360A1 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer |
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/02/2003 | WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds |
| 04/02/2003 | EP1298127A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen |
| 04/02/2003 | EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers |
| 04/02/2003 | EP1296980A1 Thiazolidinedione salt for treatment of diabetes mellitus |
| 04/02/2003 | EP1296979A1 Hetaryl-substituted heterocycles |
| 04/02/2003 | EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296977A1 Heteroaryl-phenyl substituted factor xa inhibitors |
| 04/02/2003 | EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 04/02/2003 | EP1296974A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
| 04/02/2003 | EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 04/02/2003 | EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 04/02/2003 | EP1140921B1 4-trifluoromethyl-3-oxazolylpyridines, method for producing them, products containing the same, and their use as pesticides |
| 04/02/2003 | EP1135386B1 Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives |
| 04/02/2003 | EP1135126A4 Myt1 kinase inhibitors |
| 04/02/2003 | EP1015446B1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/02/2003 | EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 04/02/2003 | EP0894089B9 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2003 | EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 04/02/2003 | EP0862560B1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors |
| 04/02/2003 | EP0850231B1 Process for preparing a 2-chloro-5-chloromethyl-thiazole compound |
| 04/02/2003 | EP0848004B1 Pyrrolidine derivatives having phospholipase a2 inhibitory activity |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407977A (Hetero) aryl-substituted heterocyclic enaminones, production therof and use thereof as herbicides, acaricides and insecticides |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1104436C Vinyl pyrrolidine cephalosporins with basic substituents |
| 04/02/2003 | CN1104430C Angiogenesis inhibiting pyridazinamines |
| 04/02/2003 | CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides |
| 04/02/2003 | CN1104427C Tricyclic inhibitors of farnesyl protein transferase |
| 04/02/2003 | CN1104419C Benzazepine derivatives with vasopressin agonistic activity |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541618 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6541492 Thiazole derivatives as PPAR gamma ligands |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 04/01/2003 | US6541423 Controlling vegatation |
| 04/01/2003 | CA2288439C Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/27/2003 | WO2003024962A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
| 03/27/2003 | WO2003024949A1 Dna-pk inhibitors |
| 03/27/2003 | WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 03/27/2003 | WO2003024943A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 03/27/2003 | WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/27/2003 | WO2003024923A1 Sulfonamide compounds as protease inhibitors |
| 03/27/2003 | WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 03/27/2003 | WO2003024453A1 Excitatory amino acid receptor antagonists |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003024401A2 Piperizinones as modulators of chemokine receptor activity |
| 03/27/2003 | WO2002101007A3 Antipathogenic benzamide compounds |
| 03/27/2003 | WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/27/2003 | WO2002096358A3 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 03/27/2003 | WO2002028844A1 Thiazole or oxazole derivatives |
| 03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
| 03/27/2003 | US20030060629 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/27/2003 | US20030060626 Fungicides |
| 03/27/2003 | US20030060625 Para-amine substituted phenylamide glucokinase activators |
| 03/27/2003 | US20030060623 Having microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tunior cells or other hyperproliferative cellular disease |
| 03/27/2003 | US20030060493 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body |
| 03/27/2003 | US20030060488 Drug comprising combination |
| 03/27/2003 | US20030060474 A piperazine compound as antithrombotic agent |
| 03/27/2003 | US20030060473 Piperazine compounds as inhibitors of MMP or TNF |
| 03/27/2003 | US20030060461 Cyclic diamine compound with condensed-ring groups |
| 03/27/2003 | US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death |
| 03/27/2003 | US20030060452 N-heterocyclic derivatives as NOS inhibitors |
| 03/27/2003 | US20030060418 Serine protease inhibitors |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/27/2003 | CA2460150A1 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 03/27/2003 | CA2459454A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 03/27/2003 | CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases |
| 03/27/2003 | CA2423885A1 Thiazole and oxazole derivatives |
| 03/26/2003 | WO2002026732A1 Benzodiazepine derivative |
| 03/26/2003 | EP1295878A1 Novel pyrazinone derivatives |
| 03/26/2003 | EP1295875A1 Heterocyclic compounds |
| 03/26/2003 | EP1295874A2 Retroviral protease inhibiting compounds |
| 03/26/2003 | EP1295867A1 Biphenyl compound |
| 03/26/2003 | EP1294716A1 Lactam inhibitors of factor xa and method |
| 03/26/2003 | EP1294715A1 Quinazoline ditosylate salt compounds |
| 03/26/2003 | EP1294714A2 Thrombin receptor antagonists |
| 03/26/2003 | EP1294702A1 Benzodiazepine derivatives as app modulators |